Company: IONQ
Filing Date: 2025-08-28
Form Type: 424B7
Source: 0001193125-25-191228
Chunk: 9

Company: IonQ, Inc.
Filing Date: 2025-08-28
Form: 424B7
Chunk 9
---
 proceeds from the sale of shares of our common stock by the selling stockholders.

S-7

SELLING STOCKHOLDERS This prospectus supplement relates to the resale by the selling stockholders referenced in this prospectus supplement of 12,377,433 shares of our common stock. This prospectus supplement covers the sale or other disposition by the selling stockholders of up to the total number of shares of our common stock issued to the selling stockholders. The table below sets forth, to our knowledge, information concerning the beneficial ownership of our common stock by the selling stockholders as of August 25, 2025. The information in the table below with respect to the selling stockholders has been obtained from the selling stockholders. When we refer to the “selling stockholders” in this prospectus supplement, we mean the selling stockholders listed in the table below as offering shares, as well as their respective pledgees, donees, transferees or other successors-in-interest.Throughout this prospectus supplement, when we refer to the shares of our common stock being registered on behalf of the selling stockholders, we are referring to the shares of our common stock issued. The selling stockholders may sell all, some or none of the shares of our common stock subject to this prospectus supplement. See “Plan of Distribution.” The number of shares of our common stock beneficially owned prior to the offering for each selling stockholder includes all common stock beneficially owned by such selling stockholder as of August 25, 2025, to our knowledge. The percentages of shares owned before the offering are based on 297,682,418 shares of our common stock outstanding as of August 25, 2025. Beneficial ownership is determined in accordance with the rules of the SEC, which generally provide that a person has beneficial ownership of a security if such person possesses sole or shared voting or investment power over that security or the right to acquire such power within 60 days. Unless otherwise indicated below, to our knowledge, each selling stockholder named in the table has sole voting and investment power with respect to the shares of our common stock beneficially owned by it, except to the extent authority is shared by spouses under applicable law. The inclusion of any shares in this table does not constitute an admission of beneficial ownership for any selling stockholder named below. Other than as described below or elsewhere in this prospectus supplement or the documents incorporated by reference herein, the selling stockholders do not have, and within the last three years have not had